CardioLogs ECG Analysis Platform vs KardiaAI
AI Verdict
Choose CardioLogs ECG Analysis Platform if…
Choose CardioLogs ECG Analysis Platform if your cardiology practice or hospital requires a comprehensive, cloud-based solution for analyzing ECG data from a diverse range of cardiac monitoring devices, including Holters and patches. This platform is ideal for organizations seeking seamless EHR integration, customizable reporting, and a pay-per-ECG model for efficient, high-volume arrhythmia detection and diagnosis.
View CardioLogs ECG Analysis Platform →Choose KardiaAI if…
Choose KardiaAI if you are a medical device manufacturer, software developer, or telehealth provider looking to integrate FDA-cleared, AI-powered ECG analysis capabilities directly into your own applications or hardware. This AI software library is best suited for embedding robust detection of conditions like AFib, bradycardia, and tachycardia, offering a flexible API for custom solution development.
View KardiaAI →When choosing between CardioLogs ECG Analysis Platform and KardiaAI, physicians should consider their practice’s specific needs for ECG data analysis. CardioLogs, now a Philips solution, excels in comprehensive, high-volume analysis of ECG data from diverse cardiac monitoring devices. Its cloud-based platform and deep neural networks are designed for rapid and efficient arrhythmia detection across various formats, including Holter monitors, smartwatches, and ECG patches. This makes it particularly well-suited for practices or institutions managing a wide array of cardiac monitoring technologies and requiring robust, centralized analysis with customizable reporting and EHR integration.
In contrast, KardiaAI by AliveCor offers an FDA-cleared AI software library primarily focused on analyzing ambulatory ECG rhythms. Its key practical difference lies in its deployment as a Software as a Medical Device (SaMD) and API library, allowing for integration into mobile apps and web platforms. While it detects various conditions like AFib, bradycardia, and tachycardia, its strength is in providing medical-grade accuracy for heart rhythm data, including more specific detections like Sinus Rhythm with PVCs or Wide QRS. Therefore, KardiaAI is ideal for physicians or developers looking to embed AI-powered ECG analysis directly into their existing applications or devices, especially those prioritizing ambulatory monitoring and specific rhythm detections within a subscription-based model.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CardioLogs ECG Analysis Platform | KardiaAI |
|---|---|---|
| Pricing | Contact sales for customized quote | Subscription-based for integrated services |
| Deployment | Cloud-based (SaaS) | Software as a Medical Device (SaMD), API library integrated into mobile apps and web platforms |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CardioLogs ECG Analysis PlatformCardioLogs offers a comprehensive, user-friendly cloud-based platform with customizable reports and EHR integration, providing a more direct and complete solution for clinicians to analyze ECG data efficiently. [3, 17, 21, 39] While KardiaAI offers strong integration capabilities, CardioLogs provides a more out-of-the-box, clinician-centric user experience with an ergonomic, state-of-the-art user interface. [39]
Clinical Value
KardiaAIWhile both are highly validated and FDA-cleared, KardiaAI, particularly with its Kardia 12L system, offers a broader range of 35 FDA-cleared cardiac determinations, including the detection of myocardial infarction and ischemia with a reduced lead set. [7, 20, 28] This represents a significant expansion of diagnostic capability beyond basic arrhythmias, performing comparably to hospital-grade ECGs. [7, 10]
Pricing & Value
KardiaAIKardiaAI provides transparent, published pricing for its KardiaCare subscription services, offering clear cost predictability for users accessing its AI-powered ECG analysis. [JSON] Tool A requires contacting sales for a customized quote, which lacks immediate pricing transparency and makes direct value comparison difficult for potential users. [JSON]
Enterprise Readiness
KardiaAIKardiaAI demonstrates superior enterprise readiness through its comprehensive security certifications, including SOC2 Type 1 and Type 2 attestations and ISO 42001 for AI Management Systems, alongside established EHR integration partnerships and widespread adoption by over 500 providers. [11, 13, 16, 22, 27, 31] While Tool A benefits from Philips backing and ISO 27001, Tool B's specific AI-focused certifications and broader integration ecosystem give it an edge. [22]
Innovation
KardiaAIKardiaAI demonstrates greater innovation by developing the world's first AI-powered, handheld 12-lead ECG system capable of detecting 35 cardiac determinations, including heart attacks, with a reduced lead set. [7, 20, 28] Its focus on democratizing access to advanced ECG diagnostics and exploring generative AI for predictive insights pushes the boundaries of current cardiac care. [20]
Support & Docs
TieBoth tools indicate the presence of support and documentation resources. Tool A, as a Philips solution, offers a dedicated Support Center and product manuals for clinicians [2, 4, 35], while Tool B, with its API/SDK, emphasizes comprehensive technical documentation and an engaged engineering support team for integrators. [11] Without more granular comparative data on the quality or breadth of these resources, it is difficult to declare a definitive winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CardioLogs ECG Analysis Platform | KardiaAI |
|---|---|---|
| Company | Cardiologs Technologies (now part of Philips) | AliveCor |
| Key Detected Conditions | Automated Arrhythmia Detection (e.g., AFib, VT) | Detection of atrial fibrillation, bradycardia, tachycardia, and normal sinus rhythm; Detection of Sinus Rhythm with Premature Ventricular Contractions (PVCs); Detection of Sinus Rhythm with Wide QRS; Detection of Sinus Rhythm with Supraventricular Ectopy (SVE) |
| Integration/Compatibility | Multi-Device Compatibility (Holter, smartwatches, ECG patches), Integration with EHR Systems | API library for integration into other ECG devices and software |
Videos
Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring CardioLogs ECG Analysis Platform or KardiaAI
Backers
Who funded each tool's parent company.